Search

everythinglearnresearchcommunity

for

Search:↓

Hirsutism is excessive hair growth in women often caused by polycystic ovarian syndrome, and identifying the cause is important for managing associated health risks.

Finasteride boosts morphine's pain relief, stops tolerance, and reduces withdrawal in rats.

Hirsutism in women often indicates a hormonal imbalance and can be managed with a combination of hormonal treatments and hair removal methods.

The Rotterdam Study updated its design and objectives in 2012, providing insights into various diseases in the elderly, including skin cancer, bone health, liver disease, neurological and psychiatric conditions, and respiratory issues.

Lower doses of treatments for hirsutism and acne in PCOS are effective and cause fewer side effects.

Citrullus colocynthis and Citrullus lanatus have potential health benefits but may also cause reproductive toxicity.

Certain hormone treatments can improve acne and related conditions in women.

Most women with excess hair growth have an underlying hormonal issue, often treated with medication and hair removal methods.

Women with PCOS often have skin problems like excessive hair, acne, hair loss, and dark patches, which can be treated with hormonal and non-hormonal therapies.

Spironolactone can cause side effects like irregular bleeding, but lower doses may reduce these effects and still improve hirsutism.

The 2018 guideline for PCOS suggests new diagnostic criteria and treatments, but recognizes the need for more research.

PCOS is a long-term condition that needs more research for better understanding and treatment.

Most women with excessive hair growth have PCOS; treatment varies and focuses on preventing new hair, with electrolysis as the only permanent removal method.

Spironolactone effectively makes hair shafts thinner in women with excessive hair growth.

5α-reductase inhibitors help treat disorders caused by DHT and have potential for future therapies.

Hyperandrogenism increases heart disease risk in premenopausal women, but this risk is linked to obesity in postmenopausal women.

Hormone therapy improves mental well-being in transgender individuals but requires ongoing health monitoring.

The document concludes that gender-affirming treatments are essential for transgender individuals and outlines safe hormone therapy practices.

The review concludes that more research is needed to better improve the health outcomes for people with Polycystic Ovarian Syndrome.

Long-term use of a certain medication can worsen erectile function in aged rats by damaging penile muscle cells.

The index to ring finger ratio may indicate disease severity in female ankylosing spondylitis patients, but not in males.

Fluridil safely promotes hair growth in men with androgenetic alopecia.

Finasteride caused long-term sexual and non-sexual side effects in young men with hair loss.

HNG may help prevent the negative effects of chemotherapy on sperm production and white blood cell counts.

Finasteride for hair loss may cause persistent sexual symptoms, depression, anxiety, and lower quality of life.

The document concludes that Rabson-Mendenhall syndrome requires novel treatments for insulin resistance and emphasizes the importance of dental care in affected patients.

Baldness may lower the risk of testicular cancer.

The document suggests various treatments for PCOS, including medication for menstrual issues, insulin resistance, and excess hair, as well as fertility treatments, while highlighting the need for personalized care and lifestyle changes.

Aldactone effectively reduces hair thickness in women with excessive hair growth, both alone and with other treatments.

Early treatment and weight management are important for teenagers with PCOS to reduce symptoms and long-term health risks.